CEO and Fund Manager, Renaissance Venture Capital Fund
Professor of Systems Biology, Columbia University
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Head of global research and development at Life Technologies
The MIT Enterprise Forum of Cambridge often spotlights successful startups and innovative tech companies, and this month it is looking at Covidien, a healthcare company the separated from Tyco in 2007. CEO Richard Meelia will share some strategy behind his company’s growth, and an investor panel focused on the medtech field will follow. The group will discuss acquisitions as an exit strategy. Register here.